throbber
Dermato-Endocrinology 3:1, 41-49; January/February/March 2011; © 2011 Landes Bioscience
`
`REVIEW
`
`An update on the role of the sebaceous gland
`in the pathogenesis of acne
`
`Evgenia Makrantonaki,1,2 Ruta Ganceviciene3 and Christos Zouboulis1·*
`
`'Departments of Dermatology, Venereology, Allergology and Immunology; Dess au Medic a I Center; Dessa u, Germany; ' Laboratory for Blogerontology;
`Derma to-Pharmacology and Derma to-Endocrinology; Institute of Clinical Pharmacology and Toxicology; Charlte Unlversltaetsmedlzln Berl In; Berlin, Germany;
`'Centre of Dermatovenereology; VIinius University Hospital Santarlsklu kllnlkos; Vllnlu s, Lithuania
`
`Keywords: sebaceous gland cells, acne, hormones, stress, inflammation, propionebacterium acnes
`
`Abbreviations: AA, arachidonic acid; ACTH, adrenocorticotropine hormone; AMPs, antimicrobial peptides; AR,
`androgen receptor; COX, cycloxygenase; CR, cannabinoid receptor; CRH, corticotropin-releasing hormone; DHEAS,
`dehydroepiandrosterone sulphate; 5a-DHT, 5a-dihydrostestosterone; DPH, diphenhydramine; GH, growth hormone;
`H -1 receptor, histamine-I receptor; hBDs, human ~ -defensins; IGF-1, insulin growth factor-I; LXR, liver-X receptor; LOX,
`lipoxygenase; LT, leucotrienes; a -MSH, a -melanocyte-stimulating hormone; MMPs, matrix metalloproteinases; MC,
`melanocortin; MUFAs, monounsaturated fatty acid; NP, neuropeptide; PG, prostaglandins; P, acnes, Propionibacterium acnes;
`POMC, propiomelanocortin; PPAR, peroxisome proliferator-activated receptor; RA, retinoic acid; RAR, retinoid acid receptor;
`RXR, retinoid X receptor; SCD, stearoyl coenzyme A; SREBP-1, sterol response element-binding protein-I; TLRs, toll-like
`receptors; TNFa, tumor necrosis factora; TRPVl, transient receptor potential vanilloid-1; VDR, vitamin D receptor
`
`The pathogenesis of acne, a disease of the pilosebaceous
`follicle and one of the most common chronic skin disorders,
`is attributed to multiple factors such as increased sebum
`lipids,
`production, alteration of the quality of sebum
`inflammatory processes, dysregulation of the hormone
`microenvironment, interaction with neuropeptides, follicular
`hyperkeratinisation and the proliferation of Propionibacterium
`acnes within the follicle. In particular, the sebaceous gland
`plays an exquisite role in the initiation of the disease as it
`possesses all the enzyme machinery for the production of
`hormones and cytokines. In addition, in response to the
`altered tissue environment in the pilosebaceous follicle as
`well as in answer to emotional fret, stress response system
`mechanisms with induction of central and local expression of
`neuropeptides, are also initiated. This review summarises the
`latest advances in understanding the role of sebaceous gland
`cells in the pathomechanism of acne.
`
`Introduction
`
`Sebaceous glands are holocrine glands found over the entire sur(cid:173)
`face of the body except the palms, soles and dorsum of the feet.
`They are largest and most concentrated in the face and scalp
`where they are the sites of origin of acne (Fig. 1). The normal
`function of sebaceous glands is to produce and secrete sebum,
`a group of complex oils including triglycerides and fatty acid
`breakdown products, wax esters, squalene, cholesterol esters and
`
`*Correspondence to: Christos C. Zoubou 11s;
`Email: chrlstos.zouboulls@kllnlkum-dessau.de
`Submitted: 09/24/10; Accepted: 10/05/10
`DOI: 10.4161/derm.3.1.13900
`
`cholesteroI. 1- 4 Schum lubricates the skin to protect against fric(cid:173)
`tion and makes it more impervious to moisture. Furthermore, the
`sebaceous gland transports antioxidants in and on the skin and
`exhibits a natural light protective activity. It possesses an innate
`antibacterial activity and has a pro- and anti-inflammatory func(cid:173)
`tion. It can regulate the activity of xenobiotics and is actively
`involved in the wound healing process.5
`In the last years, acne research has made a remarkable progress
`in understanding the mechanisms involved in the pathogenesis
`of the disease by using cell culture models and new molecular
`techniques. Mammal sebocytes and sebocyte-like cells (human,
`mouse, hamster and rat) and human sebaceous gland cell lines
`(SZ95, SEB-1, Seb-E6E7) 6•8 have been used in monolayer cul(cid:173)
`tures as models to study specific functions involved in develop(cid:173)
`ment, growth and differentiation of sebaceous gland cells. More
`complex culture systems, including three-dimensional models,
`are under development.
`
`Sebum and Acne
`
`Increased sebum excretion, alteration oflipid composition and the
`oxidant/antioxidant ratio characteristic of the skin surface lipids
`are major concurrent events associated with the development of
`acne.5 If sebum interferes with the process of follicular keratinisa(cid:173)
`tion in the pilosebaceous unit, pore blockage may occur, contrib(cid:173)
`uting to lesion formation and acne. However, seborrhoea per se is
`not considered to be the only responsible factor for the develop(cid:173)
`ment of acne, as demonstrated by the success of treatment with
`agents with no effect on sebum secretion rate that can inhibit
`the inflammatory process, such as antibiotics, topical retinoids,
`azelaic acid and benzoyl peroxide.9 The composition of the pro(cid:173)
`duced lipids is also of great importance. Lower essential fatty acid
`levels were found in wax esters in twins with acne rather than in
`
`www.landesbioscience.com
`
`Dermato-Endocrinology
`1 of9
`
`Almirall EXHIBIT 2026
`
`Amneal v. Almirall
`IPR2019-00207
`
`

`

`Figure 1. Pilosebaceous unit in facial skin of acne patients. Faintly hypertrophic sebaceous gland are observed. Dilated capillaries and perivascular
`lymphocytes (A and C) are early signs of inflammatory process in acne-involved skin. Dilated plugged orifice of hair follicle—sign of acne comedo (B).
`
`twins with no acne.10 Moreover, low levels of linoleic acid have
`been observed in skin surface lipids of acne patients.11 Evidence
`suggests that diet may be an important source of substrate for
`the synthesis of sebaceous lipids.12 This notion is supported also
`by the observation that sebum contains linoleic acid, an essential
`fatty acid that cannot be synthesised in vivo and therefore must
`be obtained from the diet. It has recently been hypothesised that
`low glycemic load diet may influence sebum production based on
`the beneficial endocrine effects of its components.13
`On the other hand, extreme caloric restriction dramatically
`decreases the sebum excretion rate and these changes can be
`reversed when a normal diet is resumed.14,15 Other studies have
`demonstrated that increased consumption of dietary fat or car-
`bohydrate increases sebum production and modifications to the
`type of carbohydrate can also alter sebum composition.16 Typical
`western diet, comprised of milk and hyperglycaemic foods,
`may have potentiating effects on serum insulin and insulin-like
`growth factor-I (IGF-I) levels, thereby promoting the develop-
`ment of acne.17
`Another hallmark of sebum in acne patients is the presence of
`lipoperoxides, mainly due to the peroxidation of squalene and a
`decrease in the level of vitamin E, the major sebum antioxidant.18
`Both lipoperoxides and monounsaturated fatty acid (MUFA) are
`capable of inducing alteration in keratinocyte proliferation and
`differentiation, whereas peroxides are capable of inducing pro-
`duction of pro-inflammatory cytokines and activation of peroxi-
`some proliferator-activated receptors (PPAR).13,18
`The biological function of sebocytes is further regulated
`by several factors including ligands of receptors expressed in
`sebocytes, such as androgens and estrogens, PPAR ligands and
`neuropeptides (NP), liver-X receptor ligands (LXR), hista-
`mines, retinoids and vitamin D. The ligand-receptor complexes
`activate pathways involving cell proliferation, differentiation,
`lipogenesis, hormone metabolism and cytokine and chemokine
`release19 (Fig. 2).
`
`LXR, which are members of the nuclear receptor superfamily,
`and play a critical role in cholesterol homeostasis and lipid metab-
`olism have been documented to regulate lipid synthesis in the
`immortalised human sebaceous gland cell line SZ95. Treatment
`of SZ95 sebocytes with LXR ligands such as TO901317 or
`22(R)-hydroxycholesterol, enhanced accumulation of lipid drop-
`lets in the cells which could be explained through induction of
`the expression of the LXRalpha receptor and known LXR tar-
`gets, such as fatty acid synthase and sterol regulatory-binding
`protein-1.20,21
`On the other hand, sebaceous function can be also signifi-
`cantly modified by histamine and conversely, antihistamines.
`Diphenhydramine (DPH), a histamine 1 receptor antagonist,
`significantly decreases squalene levels in human sebaceous gland
`cells as determined by means of high-performance liquid chro-
`matography. These data were further verified by the identifica-
`tion of histamine 1 receptor in human sebaceous glands.22
`Retinoids are also suggested to influence the biological func-
`tion of sebocytes. Retinoic acid receptors (RAR; isotypes α and
`γ) and retinoid X receptors (RXR; isotypes α, β, γ) are expressed
`in human sebocytes.23 The natural ligands for RAR and RXR are
`all-trans (atRA) and 9-cis retinoic acid (9cRA). In SZ95 sebo-
`cytes 13-cis retinoic acid (13cRA) may unfold its action through
`a marked isomerisation to atRA. All three isoforms atRA, 13cRA
`and 9cRA exhibit anti-proliferative effects24 and inhibit sebocyte
`differentiation and lipid synthesis.25 RXR agonists stimulate
`sebocyte differentiation and proliferation. The RXR agonist
`rexinoid in combination with the specific PPAR agonists, WY
`14643, troglitazone and cabaprostacyclin affect differentiation
`and growth in cultured primary sebocyte-like rat preputial cells.26
`The enzymatic machinery for the local synthesis and
`metabolism of 1, 25-dihydroxyvitamin D (3) [1,25(OH)(2)
`D(3), calcitriol] has been also investigated in human sebocytes.
`Vitamin D receptor, vitamin D-25-hydroxylase, 25-hydroxyvi-
`tamin D-1alpha-hydroxylase and 1, 25-dihydroxyvitamin
`
`42
`
`Dermato-Endocrinology
`
`Volume 3 Issue 1
`
`2 of 9
`
`

`

`Genetic/ extrinsic factors
`
`sex steroids/
`
`growth factors ~
`
`LXR ligands - - (cid:173)
`
`•
`histamines ~
`
`~ PPAR ligands
`0.--- neuropeptides
`
`cytokines ------.(cid:173)
`
`•
`
`vitamin D
`
`~
`
`ell prol;fe,atlon
`
`• cell differentiation
`
`• lipogenesis
`
`• hormone metabolism
`
`• cytokine and chemokine release
`
`Figure 2. Regulation of the biological function of human sebaceous gland cells.
`Schematic overview. [LXR: liver X receptors, PPAR: peroxisome-proliferator activated
`receptors].
`
`D-24-hydroxylase are expressed in SZ95 sebocytes
`in vitro. Furthermore, incubation of SZ95 sebocytes
`with 1,25(OH)(2)D(3) leads to a dose-dependent
`modulation of cell proliferation, cell cycle regulation,
`lipid content and interleukin (IL)-6/IL-8 secretion in
`vitro.27 In hamster auricular sebocytes while epider-
`mal growth factor and atRA can decrease the intracel-
`lular accumulation of triglycerides and free fatty acids
`in the cells, 1α, 25-dihydroxyvitamin D3 decreases
`the triglyceride level but augments the accumulation
`of wax esters. No difference has been detected in the
`level of cholesterol after the above treatments.28
`
`Effects of Hormones
`on Sebaceous Gland Cells
`
`Sex steroids. Several studies have demonstrated that
`there is an association between local overproduction
`of active androgens and acne. Acne patients produced
`higher rates of testosterone and 5α-dihydrotestosterone
`(5α-DHT) in their skin than healthy individuals.29
`High testosterone levels have been implicated with
`enhanced sebaceous gland activity in humans30,31 and
`consequently with diseases marked by hyperseborrhea,
`such as Acne vulgaris. However, only a few patients
`with androgenic disorders exhibit hyperandrogenemia, an observa-
`tion which indicates the predominance of peripheral tissue events
`for the occurrence of clinical signs.32
`Enhanced sebaceous gland activity is attributed to the potent
`androgen 5α-DHT5 as sebaceous gland cells possess all necessary
`enzymes for conversion of testosterone to 5α-DHT.33 The isozyme
`5α-reductase type I, which catalyses the conversion from testos-
`terone to 5α-DHT in peripheral tissues by a NADPH-dependent
`reaction is expressed predominantly in skin. It is present in the
`cytoplasm and cell membrane compartment in skin cells34 and
`particularly in facial sebocytes,33 illustrating the key role of seba-
`ceous gland cells in androgen metabolism.
`The effects of testosterone and 5α-DHT are mediated by bind-
`ing to the nuclear androgen receptor (AR), also expressed in human
`sebaceous gland cells.35 AR is a member of the steroid superfamily
`of ligand-dependent transcription factors. 5α-DHT binds to the
`AR with greater affinity than testosterone and the 5α-DHT/AR
`complex appears to be more stable36 and therefore, more effective.
`In contrast to the in vivo observations, in vitro experiments
`with human sebocytes have shown that testosterone affects pro-
`liferation in a dose-dependent manner6,37 but does not affect lipid
`synthesis.38,39 This contradiction has led to the assumption that
`co-factors may be required for the induction of the entire so-called
`androgenic influence of the sebaceous gland.40 Current research
`has indicated that PPAR and their ligands, may be the primary
`candidates.38,39 PPAR regulate multiple lipid metabolism genes
`in mitochondria, peroxisomes and microsomes, all prominent in
`sebocyte cytoplasm.38,39
`Indeed, Rosenfield et al.38 have previously demonstrated the
`interaction of 5α-DHT with PPAR ligands in inducing differ-
`entiation of sebocyte-like rat preputial cells and lipid synthesis.
`
`PPARα is the most important PPAR that regulates lipid synthesis
`and inflammation.40,41 In addition, PPAR-α, -δ, -γ1 and -γ2 have
`been shown to be expressed at mRNA and protein levels in SZ95
`sebocytes.39
`Dehydroepiandrosterone (DHEA) has been also shown to reg-
`ulate sebum production especially in postmenopausal women.22
`Consequently, several researchers have suggested the use of
`DHEA as an anti-aging agent.42,43 However, in in vitro experi-
`ments DHEA has been shown to have no direct effect on the bio-
`logical activity of human sebocytes. Substitution with DHEA in
`elderly persons is accompanied by a small increase of testosterone
`and estradiol, which may indeed yield an explanation of the clini-
`cal change demonstrated22 suggesting that the action of DHEA
`may be implemented through indirect pathways.
`Growth factors. Growth hormone (GH) activity is consid-
`ered to be mainly attributed to IGF but GH has also been shown
`to exhibit direct effects on human skin cells.44 The increased
`serum GH levels in acromegaly are associated with enhanced
`sebum secretion,45 an observation that could be confirmed by
`GH treatment of human SZ95 sebocytes in vitro.46 In acne vul-
`garis, increased sebum production peaks in mid-adolescence at
`a time that GH and IGF-I reach their highest serum levels.47 In
`mini rats, suppression of GH gene expression by an antisense
`transgene, leads among to thinner skin with less collagen and
`increase of subcutaneous adipose tissue also to small-sized seba-
`ceous glands.48
`Increased serum levels of IGF-I have been observed in adult
`women and men with acne and the number of total acne lesions,
`inflammatory lesions, serum levels of 5α-DHT and DHEA sul-
`phate, each correlated with serum IGF-I levels in women with
`acne.49,50 A correlation between the mean facial sebum excretion
`
`www.landesbioscience.com
`
`Dermato-Endocrinology
`
`43
`
`3 of 9
`
`

`

`rate and serum IGF-I levels has been demonstrated in postado-
`lescent acne patients.51 IGF-I has been localised to the peripheral
`cells of sebaceous glands in the rat,52 while in human skin the
`strongest expression of IGF-I protein has been found in maturing
`sebocytes and suprabasal cells of sebaceous ducts.53 The expres-
`sion of IGF-I receptor mRNA is the strongest in basal cells of
`sebaceous glands and immature sebocytes, whereas IGF-I recep-
`tor protein expression was uniform and intense in all regions of
`the gland.53 In animal studies, IGF-I has been shown to stimulate
`sebocyte differentiation in vitro especially in combination with
`GH,47 while in human keratinocytes it acts as a mitogen.54 On the
`other hand, in humans, IGF-I plays a key role in the induction of
`lipid synthesis in human sebocytes.46,55 In SEB-1 sebocytes, IGF-I
`increases lipogenesis by the induction of sterol response element-
`binding protein-1 (SREBP-1)55 through activation of PI3K/Akt
`and MAPK/ERK-signal transduction pathway.56 SREBP-1 pref-
`erentially regulates genes of fatty acid synthesis.56 In the hamster
`ear sebaceous model, androgens rapidly induce the expression of
`SREBP-1.57 In addition, an interaction between the IGF-I and
`estradiol signalling pathway has been described in human SZ95
`sebocytes, implicating that estrogens may have an indirect effect
`on the pathogenesis of acne.46
`Recent data suggest that incubation of human sebaceous
`gland cells with a hormone mixture consisting of growth fac-
`tors and sex steroids at age-specific levels may alter the biological
`activity of the cells by regulating their transcriptome and thus
`illustrate the importance of the hormone environment for cell
`function.58 Human SZ95 sebocytes treated with hormone lev-
`els that can be found in 60 year-old women produce less lipids
`than sebocytes treated with a hormone mixture representing
`that found in serum of 20 year-old women.58 Gene expression
`profiling via cDNA microarray between SZ95 sebocytes under
`the 20 and 60 year-old hormone mixture detected differentially
`expressed genes, which are involved in biological processes such
`as DNA repair and stability, mitochondrial function, oxidative
`stress, cell cycle and apoptosis, ubiquitin-induced proteolysis and
`transcriptional regulation. The most significantly altered signal-
`ling pathway was that of transforming growth factor-β (TGFβ).
`A disturbed function of this cascade has been also associated with
`tumourigenesis, i.e., in pancreatic, prostate, intestine, breast and
`uterine cancer. Interestingly, genes expressed in signalling path-
`ways operative in age-associated diseases such as Huntington’s
`disease, dentatorubral-pallidoluysian atrophy and amyotrophic
`lateral sclerosis were also identified. These data demonstrate that
`hormones interact in a complex fashion, and sebocytes may be
`affected to a large extent by the changes in their circulating blood
`levels with age.58
`
`Effects of NPs on Sebaceous Gland Cells
`
`NP are a heterogeneous group of biologically active peptides that
`are present in neurons of both the central and peripheral ner-
`vous systems. However, human skin and in particular the human
`sebaceous gland has been shown to express functional recep-
`tors for NP, such as corticotropin-releasing hormone (CRH),
`melanocortins, β-endorphin, vasoactive intestinal polypeptide,
`
`neuropeptide Y and calcitonin gene-related peptide. These recep-
`tors modulate the production of inflammatory cytokines, prolif-
`eration, differentiation, lipogenesis and androgen metabolism in
`human sebocytes.5
`CRH the most proximal element of the hypophysis-pituitary-
`adrenal (HPA) axis acts as central coordinator for neuroendo-
`crine and behavioural responses to stress. It has been shown that
`CRH, CRH-binding protein, CRH-receptor®1 and CRH-R2
`are expressed in SZ95 sebocytes at mRNA and protein level,
`while CRH-R1 is the predominant type (CRH-R1/CRH-R2 =
`2). In addition, CRH significantly induces sebaceous lipids pro-
`duction, IL-6 and -8 synthesis and may upregulate mRNA levels
`of 3β-hydroxysteroid dehydrogenase/Δ5-4 isomerase.59,60 In acne-
`involved skin the complete CRH system is abundant especially in
`the sebaceous glands (Fig. 3), possibly activating pathways which
`affect immune and inflammatory processes leading to the devel-
`opment and stress-induced exacerbation of acne.61
`Melanocortin (MC) peptides can also directly affect the
`function of human sebocytes via MC receptors. α-Melanocyte-
`stimulating hormone (α-MSH) has been demonstrated to act as
`a modulator of the rat preputial gland, a specialised sebaceous
`gland-like structure of rodents.62 The presence of both MC-1R
`and MC-5R which bind α-MSH were detected in primary cell
`cultures of facial human sebocytes. The expression of MC-5R is
`weaker than that of MC1-R but it has been shown to be a marker
`of human sebocyte differentiation, since it is expressed in dif-
`ferentiated, lipid-containing sebocytes only.63,64 In acne-involved
`skin, sebocytes and keratinocytes of the ductus seboglandularis
`showed very intense MC-1R expression in contrast to less intense
`scattered immunoreactivity in normal skin samples suggesting
`that this receptor is involved in the initiation of acne.65 MC-1R
`expression has been shown to be upregulated by proinflamma-
`tory signals.66,67 As proinflammatory cytokines are upregulated
`in acne lesions,68 sebocytes may respond to these signals with
`increased MC-1R expression, thereby generating a negative feed-
`back mechanism for α-MSH which exerts direct anti-inflamma-
`tory actions, i.e., inhibition of IL-1-mediated IL-8 secretion.64,65
`Cannabinoid receptors (CR), which mediate the psychophar-
`macological action of marijuana have been not only localised in
`the central and peripheral nervous system but also in human skin.
`CR1 and 2 are expressed in human sebaceous glands,69 whereas the
`CB2 and other prototypic endocannabinoids are present in SZ95
`sebocytes and may induce in a dose-dependent manner lipid pro-
`duction and cell death. These actions are selectively mediated by
`CB2-coupled signalling involving the MAPK pathway.70
`Other NP such as substance P or vasointestinal peptide may
`also be involved in the pathogenesis of acne vulgaris Substance
`P, which can be elicited by stress may promote the development
`of cytoplasmic organelles in sebaceous cells, stimulate sebaceous
`germinative cells, and induce significant increases in the area of
`sebaceous glands. It also increases the size of individual sebaceous
`cells and the number of sebum vacuoles for each differentiated
`sebaceous cell, all of which suggests that substance P promotes
`both the proliferation and the differentiation of sebaceous
`glands. Substance P induces the expression of neutral endopep-
`tidase, a potent NP-degrading enzyme, in sebaceous germinative
`
`44
`
`Dermato-Endocrinology
`
`Volume 3 Issue 1
`
`4 of 9
`
`

`

`Figure 3. Localisation of CRH immunostaining in the sebaceous gland of acne patients (A) and in the normal skin of healthy controls (B). Very intensive
`expression of the gene in all types of sebocytes—basal, differentiating and mature cells—and keratinocytes of ductus seboglandularis in acne skin
`is shown (A) (x400); significant weaker and dependent upon sebocytes differentiation stage immunoreaction of sebaceous gland in normal skin (B)
`(x400).
`
`cells and of E-selectin by perisebaceous venules. Facial skin from
`acne patients is characterised by rich innervation, by increased
`numbers of substance P-containing nerves and mast cells, and by
`strong expression of neutral endopeptidase in sebaceous glands
`and E-selectin in venules around sebaceous glands, compared
`with normal skin.71 The ectopeptidases dipeptidyl peptidase
`IV (DP IV or CD26) and aminopeptidase N (APN or CD13),
`which have been shown to be involved in the degradation of sev-
`eral NP, especially of substance P, have been found to be highly
`expressed in human sebocytes in vivo and in vitro. Further stud-
`ies have shown unexpectedly that inhibitors of DP IV and APN
`can suppress proliferation and slightly decrease neutral lipids,
`but can also enhance terminal differentiation in SZ95 sebocytes.
`This suggests that ectopeptidases may be new targets to modulate
`certain sebocyte functions, and that ectopeptidase inhibitors may
`have potential therapeutic roles in acne pathogenesis.72
`A central integrator of nociception, the transient recep-
`tor potential vanilloid-1 (TRPV1) is expressed in human skin,
`sebaceous glands in situ and in SZ95 sebocytes in vitro. It has
`
`been documented that the prototypic TRPV1 agonist, capsaicin,
`selectively inhibits basal and arachidonic acid-induced lipid syn-
`thesis in a dose-, time- and extracellular calcium-dependent and
`TRPV1-specific manner. Low-dose capsaicin stimulates cellular
`proliferation via TRPV1, whereas higher concentrations inhibit
`sebocyte growth and induce cell death independent of TRPV1.73
`These findings suggest the strong involvement of neurogenic fac-
`tors and sebocytes in the disease process of acne.
`
`(cid:44)(cid:81)(cid:193)(cid:68)(cid:80)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15) (cid:54)(cid:72)(cid:69)(cid:68)(cid:70)(cid:72)(cid:82)(cid:88)(cid:86) (cid:42)(cid:79)(cid:68)(cid:81)(cid:71) (cid:38)(cid:72)(cid:79)(cid:79)(cid:86) (cid:68)(cid:81)(cid:71) (cid:36)(cid:70)(cid:81)(cid:72)
`
`Inflammation is being regarded as a key component of the patho-
`genesis of acne.74 In the last few years, there has been a debate as
`to whether hyperkeratinisation of the follicular duct precedes the
`influx of inflammatory cells or vice versa. Recent studies support
`the latter hypothesis by demonstrating that an increase in IL-1
`activity occurs before the hyperproliferation around uninvolved
`follicles and this triggers the activation of the keratinocytes.68,75
`Expression profiling of acne-involved and uninvolved skin from
`
`www.landesbioscience.com
`
`Dermato-Endocrinology
`
`45
`
`5 of 9
`
`

`

`proliferation and may play a profound role in the transformation
`of a normal follicle into an acne lesion.68
`Inflammation is further characterised by action of active lipid
`mediators, such as leucotrienes (LT), prostaglandins (PG) and
`15-hydroxyeicosatetraenoic acids (15-HETE). These molecules are
`synthesised from arachidonic acid (AA) or linolenic acid by the
`enzymes lipoxygenase (LOX) and cyclooxygenase (COX), respec-
`tively. Both COX isozymes, COX-1 and COX-2, are expressed
`in human sebocytes in vitro, in particular COX-2 expression is
`selectively upregulated in acne involved sebaceous glands in vivo41
`(Fig. 4). In hamster sebocytes the expression of COX-2 has been
`also documented,78 while the 15-desoxy-Δ12,14-PGJ2 has been
`shown to induce the lipid synthesis in the cells.79 Activation of the
`platelet-activating factor signalling pathway (PAF, 1-O-alkyl-2-
`acetyl-sn-glycero-3-phosphocholine) which consists of a group of
`phosphocholines with various biological effects, including modula-
`tion of keratinocyte function and skin inflammation, can regulate
`the expression of inflammatory mediators, e.g., COX-2 and PGE2,
`as well as IL-8 in SZ95 sebocytes.80 Transgenic keratin 5 promoter
`driven overexpression of COX-2 in the basal compartment of the
`epidermis of the mouse and increased PGE2 levels have been doc-
`umented to cause sebaceous gland hyperplasia and overshooting
`sebum production pointing to a role of COX-2-mediated PGE2
`synthesis in this process.81 Activation of PPARγ by UVB irradia-
`tion and the potent lipid soluble oxidant tert-butylhydroperoxide
`(TBH) induces COX-2 expression in SZ95 sebocytes and this find-
`ing indicates a PPARγ COX-2-mediated pathway regulating sebo-
`cyte proliferation and/or lipogenesis.82
`LT are potent proinflammatory mediators and neutrophil
`attractants produced from arachidonic acid by the enzyme 5-LOX.
`Human sebocytes express all necessary enzymes for a functional LT
`pathway. The enzymes 5-LOX and LTA4 hydrolase are expressed
`in SZ95 sebocytes at protein and mRNA level. These enzymes are
`essential for the formation of LTB4. On the other hand, 15-LOX
`expression shows a weak expression in SZ95 sebocytes, indicating
`that sebocytes do not play a significant role in the biosynthesis of
`the anti-inflammatory 15-HETE. Treatment of SZ95 sebocytes
`with AA stimulates 5-LOX expression and induces LTB4 synthe-
`sis.41 In addition, AA induces the expression of the IL-6 and IL-8
`cytokines. 5-LOX and LTA4 hydrolase show a stronger expression
`in acne lesions than in normal skin and in uninvolved skin of acne
`patients.41 The involvement of 5-LOX in the pathogenesis of acne
`has led to new therapeutic strategies to deal with the disease.83
`Cytokines are present in normal sebaceous glands, and they are
`affected by many factors. IL-1α, TNFα, IL-6 and IL-8 are released
`into supernatant in unstressed sebocyte culture.41 In a stressed
`environment, the amounts of released cytokines increase signifi-
`cantly. AA and calcium ionophore enhance the level of IL-6 and
`IL-8, but that of IL-1β and TNFα is not affected.9,41
`Psoriasin, a member of the S100 gene family, was shown to be
`highly expressed in the epidermis and the ductus seboglandularis
`of acne-involved skin in contrast to uninvolved control.84 Psoriasin
`has been suggested to be involved in the pathogenesis of several
`inflammatory skin diseases, and its levels increase in response to
`inflammatory stress. RA and inflammatory agents have been also
`implicated in the upregulation of psoriasin.85,86
`
`Figure 4. Localisation of COX-2 immunostaining in the sebaceous gland
`of acne patients (A) and in the normal skin of healthy controls (B). Very
`strong immunoreaction of the gene within the sebaceous gland of acne
`skin, especially, in undifferentiated and early differentiated sebocytes
`is seen (A) (x400). Weak immunoexpression of COX-2 in the sebaceous
`gland and ductal cells of healthy skin (B) (x400).
`
`acne patients and from subjects without acne via cDNA micro-
`arrays have given us a better insight into the etiological factors
`giving rise to acne.76 In inflammatory acne lesions, the major-
`ity of the regulated genes, which showed to be upregulated are
`involved in inflammatory processes. These include matrix metal-
`loproteinases, β-defensin 4, IL-8 and granulysin. No differ-
`ences were noted between normal skin from acne patients and
`that from patients without acne in the array analysis. NFκB, a
`transcription factor critical for upregulation of many proin-
`flammatory cytokine genes has been shown to be activated in
`acne lesions.77 NFκB-regulated cytokine mRNA genes levels
`of TNFα, IL-1β, IL-8 and IL-10 are significantly upregulated
`in acne-involved skin compared to uninvolved normal adjacent
`skin. Elevated expression of the chemokine IL-8 is able to attract
`circulating inflammatory cells into the tissue. Indeed, in lesional
`skin of acne, there is a marked increase in the presence of neutro-
`phils, as compared to the uninvolved skin whereas lymphocytes
`are prominently visible in inflammatory acne lesions as compared
`to normal controls.77 Another transcription factor involved in
`inflammation, AP-1 has been shown to be activated in inflamma-
`tory acne lesions in vivo as well. Levels of the proinflammatory
`cytokine IL-1 were also upregulated perifollicularly in unin-
`volved skin from acne patients. This cytokine may be responsible
`for the cutaneous inflammation and the resulting keratinocyte
`
`46
`
`Dermato-Endocrinology
`
`Volume 3 Issue 1
`
`6 of 9
`
`

`

`Propionibacterium acnes (p. acnes)
`
`P. acnes is a gram-positive anaerobic bacterium which with other
`non-pathogenic microorganisms, such as coagulase negative staph-
`ylococci and diphtheroid rods, resides in pilosebaceous follicles as a
`member of the resident bacterial flora. The mechanism by which P.
`acnes contributes to the pathogenesis of acne is debated. While in
`several studies it could be shown that P. acnes numbers are higher
`in acne patients than in healthy individuals, other studies found no
`difference between the numbers of P. acnes in affected and non-
`affected follicles. Nevertheless, an abnormal colonisation by P.
`acnes has been implicated in the occurrence of acne via the induc-
`tion of inflammatory mediators. The bacteria stimulate the pro-
`duction of proinflammatory cytokines, including interleukins-1β,
`-8 and -12, and TNFα. It is known that P. acnes-induced cytokine
`production is mediated by Toll-like receptor (TLR) 2.87-90 The
`pilosebaceous unit is an immunocompetent organ. Keratinocytes
`and sebocytes may act as immune cells capable of pathogen rec-
`ognition and abnormal lipid presentation. Both cell types can be
`activated by P. acnes via toll-like receptors (TLR), CD14 and CD1
`molecules.88 The expression of TLR2, TLR4, TLR6 and CD14
`has been already documented in SZ95 sebocytes.91,92 Recent evi-
`dence has indicated that human sebaceous glands may contribute
`to the skin immune defense by releasing antimicrobial peptides
`(AMP). For example, human β-defensins (hBD) are expressed in
`human pilosebaceous units and their expressio

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket